New Age Alpha Advisors, LLC Tg Therapeutics, Inc. Transaction History
New Age Alpha Advisors, LLC
- $2.23 Trillion
- Q1 2025
A detailed history of New Age Alpha Advisors, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, New Age Alpha Advisors, LLC holds 6,823 shares of TGTX stock, worth $239,964. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,823
Previous 7,082
3.66%
Holding current value
$239,964
Previous $213 Million
26.21%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding TGTX
# of Institutions
416Shares Held
88.1MCall Options Held
2.34MPut Options Held
1.94M-
Vanguard Group Inc Valley Forge, PA15.6MShares$549 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$401 Million0.0% of portfolio
-
State Street Corp Boston, MA7.43MShares$261 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.28MShares$115 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.85MShares$100 Million9.29% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.11B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...